Amrix FDA Approval History
FDA Approved: Yes (First approved February 1, 2007)
Brand name: Amrix
Generic name: cyclobenzaprine
Dosage form: Extended-Release Capsules
Company: ECR Pharmaceuticals
Treatment for: Muscle Spasm
Amrix is an extended-release formulation of the skeletal muscle relaxant cyclobenzaprine, indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Development timeline for Amrix
| Date | Article |
|---|---|
| Feb 1, 2007 | Approval Amrix Approved - ECR Pharmaceuticals - relief of muscle spasm associated with acute, painful musculoskeletal conditions |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.